Bisoprolol and Glaucoma: Safety and Clinical Considerations
Key Clinical Points
- The American Heart Association recommends that bisoprolol is safe to use in patients with glaucoma, as systemic beta-blockers like bisoprolol can actually provide the additional benefit of lowering intraocular pressure (IOP) 1
- Oral beta-blockers, including bisoprolol, reduce intraocular pressure by decreasing aqueous humor production, though they are not used primarily to treat glaucoma due to their systemic effects 1
- The IOP-lowering effect of bisoprolol may provide a significant additional benefit, particularly in elderly patients with both hypertension and glaucoma 1
Specific Cardiovascular Risks
- Topical timolol eye drops can cause significant systemic absorption leading to bradycardia and reduced blood pressure despite being administered ophthalmically 2
- Some patients requiring timolol for glaucoma have required pacemaker implantation due to severe bradycardia 1, 2
- Elderly patients face higher risk for systemic effects, especially with concurrent topical and systemic beta-blocker use 2
Clinical Management Algorithm
- The American Academy of Ophthalmology recommends reviewing current glaucoma medications and considering switching to prostaglandin analogs as first-line glaucoma therapy in patients already on bisoprolol 3, 4
- Prostaglandin analogs (latanoprost, bimatoprost, travoprost, tafluprost) are the most frequently prescribed initial therapy, most efficacious, and have once-daily dosing 3, 4
- The American Academy of Ophthalmology specifically identifies cardiac arrhythmia as a comorbidity deserving consideration when patients are using topical ocular hypotensive agents 3